Father's Day Sale! 20% OFF Use Code DAD20 *
Mometamax Otic Suspension for Dogs is a powerful, once-daily ear treatment designed to relieve and resolve ear infections caused by susceptible bacteria and fungi. This veterinarian-recommended otic suspension combines three potent active ingredients—gentamicin sulfate (antibacterial), mometasone furoate (anti-inflammatory corticosteroid), and clotrimazole (antifungal)—to provide comprehensive relief from otitis externa and related symptoms such as itching, inflammation, and discharge.
Gentamicin sulfate eliminates bacteria by disrupting their protein production. Clotrimazole targets yeast and fungal organisms commonly responsible for otitis externa, such as Malassezia pachydermatis. Mometasone furoate, a synthetic corticosteroid, reduces inflammation, redness, and itching caused by allergic reactions or chronic ear infections.
Mometamax is indicated for the treatment of otitis externa in dogs caused by susceptible strains of fungi and bacteria, including:
Note: Always consult your veterinarian before using Mometamax Otic Suspension. Not for use in cats unless directed by a veterinarian.
Mometamax is a registered trademark of Intervet Inc., d/b/a Merck Animal Health, a subsidiary of Merck & Co., Inc.
View Mometamax Otic Suspension Drug Facts Sheet.
Before using Mometamax Otic Suspension, clean and dry your dog’s external ear canal thoroughly. Ensure the eardrum (tympanic membrane) is intact before administering the medication.
Treatment should continue for 7 consecutive days unless otherwise directed by your veterinarian.
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Gentamicin: Risk of nephrotoxicity, vestibular, and cochlear damage if used improperly or on damaged skin.
Mometasone: May cause liver enzyme elevations, appetite changes, increased thirst/urination, and in rare cases, signs of Cushing's syndrome.
Clotrimazole: Rarely causes skin irritation, redness, itching, or swelling.
General Observations: In clinical trials, less than 1% of dogs experienced side effects such as ataxia, proprioceptive deficits, increased water consumption, inflammation of the pinna, or diarrhea.